Key result
Congestive heart failure affects approximately 5 million Americans, with modern drug therapy focusing on improving survival using ACE inhibitors, beta-blockers, and hydralazine plus a nitrate.
Answers are grounded in this paper and cite their sources.
This review highlights the shift in heart failure management from symptom control to improving survival using disease-modifying therapies like ACE inhibitors and beta-blockers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Skrabal et al. (2000) conducted a review in Congestive Heart Failure. Heart failure therapies was evaluated. Congestive heart failure affects approximately 5 million Americans, with modern drug therapy focusing on improving survival using ACE inhibitors, beta-blockers, and hydralazine plus a nitrate.
Synapse has enriched 10 related papers. Consider them for comparative context: